quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:00·43d
PRRelease
Insulet Corporation logo

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

PODD· Insulet Corporation
Health Care
Original source

Companies

  • PODD
    Insulet Corporation
    Health Care

Recent analyst ratings

  • Apr 7UpdateCitigroup$230.00
  • Jan 27UpdateTD Cowen$294.00
  • Jan 12UpdateBarclays$274.00
  • Dec 16UpdateEvercore ISI$370.00
  • Nov 19UpdateUBS$400.00
  • Oct 21UpdateStifel$370.00

Related

  • ANALYST16d
    Insulet downgraded by Citigroup with a new price target
  • SEC17d
    SEC Form DEFA14A filed by Insulet Corporation
  • SEC17d
    SEC Form DEF 14A filed by Insulet Corporation
  • INSIDER21d
    SEC Form 4 filed by Panos Michael
  • INSIDER21d
    SEC Form 3 filed by new insider Panos Michael
  • INSIDER21d
    SEC Form 4 filed by Huffines Robert Luther
  • PR22d
    Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
  • PR24d
    Insulet Appoints Mike Panos as Chief Commercial Officer
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022